MENU
LQDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Liquidia (LQDA) Ownership - Who owns Liquidia?

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease... Show more

Profile

Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
216
Web
https://www.liquidia.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
6.71B
P/E Ratio
443.79
Total Cash
222.79M
Projected Growth
N/A
Total Debt
184.82M
Revenue
288.07M
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
2.51
Total Debt/Equity
N/A
Revenue/Share
3.20 USD as % of share price
View a ticker or compare two or three
LQDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
216
Web
https://www.liquidia.com